R-Pharm US
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 3096, Princeton, New Jersey, 0854...Phone Number
(609) 512-1739Website
www.rpharm-us.comRevenue
<$5 MillionIndustry
About R-Pharm US
R-PHARM US is a fully integrated specialty pharmaceutical company established in 2014 and located in Princeton, NJ. The company focuses on the development and commercialization of specialty medicines for the treatment of cancer and chronic immune diseases. Notably, R-PHARM US acquired IXEMPRA (ixabepilone) from Bristol-Myers Squibb, successfully treating over 20,000 metastatic breast cancer patients in the past six years. Their intended clients include patients suffering from cancer and chronic immune diseases.Explore more
R-Pharm US Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to R-Pharm US
Compare insights from companies similar to R-Pharm US, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
R-Pharm US Tech Stack
A closer look at the technologies used by R-Pharm US
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding R-Pharm US
Sign Up For FreeTo access detailed company insights
R-PHARM US is a fully integrated specialty pharmaceutical company established in 2014 and located in Princeton, NJ. The company focuses on the development and commercialization of specialty medicines for the treatment of cancer and chronic immune diseases. Notably, R-PHARM US acquired IXEMPRA (ixabepilone) from Bristol-Myers Squibb, successfully tr... Read More
